ストックスクリーナーアプリを入手
2.10
1.41%
-0.03
前日終値:
$2.13
開ける：
$2.25
24時間の取引高:
37,674
Relative Volume:
0.24
時価総額：
$56.80M
収益：
-
当期純損益:
$-14.47M
株価収益率:
-1.6935
EPS:
-1.24
ネットキャッシュフロー:
$-12.19M
1週間 パフォーマンス:
-6.25%
1か月 パフォーマンス:
-30.00%
6か月 パフォーマンス:
-28.08%
1年 パフォーマンス:
+9.95%
1日の値動き範囲:
$2.0959
$2.254
1週間の範囲:
$2.02
$2.3201
52週間の値動き範囲:
$1.35
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
BEAT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
2.0959 | 56.80M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
216.16 | 35.28B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
68.31 | 11.91B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
52.95 | 9.75B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
100.97 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.25 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-09-11 | 開始されました | Needham | Buy |
| 2020-09-02 | 開始されました | Robert W. Baird | Neutral |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-08-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-07-26 | 繰り返されました | Lake Street | Buy |
| 2018-04-26 | 繰り返されました | The Benchmark Company | Buy |
| 2018-02-23 | 繰り返されました | Dougherty & Company | Buy |
| 2017-11-08 | 繰り返されました | Dougherty & Company | Buy |
| 2017-10-26 | 開始されました | Raymond James | Outperform |
| 2017-10-24 | 開始されました | SunTrust | Buy |
| 2017-08-09 | 繰り返されました | Dougherty & Company | Buy |
| 2017-07-19 | 繰り返されました | The Benchmark Company | Buy |
| 2017-04-11 | 繰り返されました | Dougherty & Company | Buy |
| 2016-12-02 | 開始されました | Dougherty & Company | Buy |
| 2016-09-13 | 開始されました | Sidoti | Buy |
| 2016-08-03 | 繰り返されました | The Benchmark Company | Buy |
| 2015-07-28 | 繰り返されました | Dougherty & Company | Buy |
| 2013-10-24 | 開始されました | The Benchmark Company | Buy |
| 2013-08-21 | 開始されました | Dougherty & Company | Buy |
すべてを表示
Heartbeam Inc (BEAT) 最新ニュース
JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail
HeartBeam (NASDAQ: BEAT) To Present At JP Morgan 2025 Annual Healthcare Conference - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam to Showcase FDA-Cleared Revolutionary Heart Monitor at JP Morgan Healthcare Conference - StockTitan
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference - Business Wire
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance - Yahoo! Voices
FDA clearance adds glow to Heartbeam prospects - BioWorld Online
HeartBeam Wins FDA Nod for Home High-Fidelity Heart Monitor - MPO-mag
HeartBeam announces FDA clearance for high-fidelity ECG system - TipRanks
Heartbeam stock soars to 52-week high, hits $3.48 - Investing.com
FDA clears HeartBeam's novel ECG system for arrhythmia - Investing.com India
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology - Business Wire
HeartBeam And 2 Other US Penny Stocks With Promising Potential - Simply Wall St
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
HeartBeam rises on positive data from two studies on its vector-based technology - MSN
HeartBeam ECG technology shows promise in clinical studies By Investing.com - Investing.com Australia
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference - BioSpace
HeartBeam Touts Data from Study of Vector-Based Tech - MPO-mag
HeartBeam ECG technology shows promise in clinical studies - Investing.com India
HeartBeam announces positive data from two studies at AHA - TipRanks
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Update - Defense World
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions - Barchart
HeartBeam reports net loss of USD 5M in Q3 2024 - Medical Buyer
HeartBeam, Inc. Advances Cardiac Monitoring Solutions - TipRanks
HeartBeam Q3 Loss Widens to $5M as FDA Review Advances for Cardiac Tech | BEAT Stock News - StockTitan
Spotlight On US Penny Stocks In October 2024 - Simply Wall St
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire
Tripp Investments Alters Stake in Betmakers - MSN
Severfield PLC Executes Share Buy-Back on LSE - MSN
HeartBeam, Inc. (BEAT): A Bull Case Theory - Insider Monkey
HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care - Barchart
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire
HeartBeam Appoints Robert Eno as New CEO - TipRanks
Upstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN
Diamondback Energy (FANG) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN
Lifesaving Portable, AI Augmented Cardiac Monitoring - openPR
HeartBeam names Robert Eno as new CEO for growth phase - Investing.com
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire
HeartBeam Appoints Robert Eno as Chief Exec - MPO-mag
Dr. Lance Myers Joins HeartBeam As Chief AI Scientist - MPO-mag
Dr. Lance Myers Joins HeartBeam as Chief AI Scientist - MPO-mag
Short Interest in HeartBeam, Inc. (NASDAQ:BEATW) Decreases By 17.6% - Defense World
HeartBeam appoints AI expert Lance Myers as Chief Scientist - Investing.com
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist - Business Wire
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation - Simply Wall St
Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth? - Yahoo Finance
Timothy Cruickshank named HeartBeam CFO - Medical Buyer
Heartbeam stock retains Speculative Buy rating despite near-term risks - Investing.com India
HeartBeam Names Timothy Cruickshank As CFO - MPO-mag
Heartbeam Inc (BEAT) 財務データ
収益
当期純利益
現金流量
EPS
0.92%
大文字化:
|
ボリューム (24 時間):